Save money and time, get standardized analysis. One of the broadest coverage of EU markets. Our key value proposition is provision of high quality pan-European support
Analyses from the same vendor for 34 different EU countries
We will help you navigate through the challenges of reimbursement and funding for medical devices and in-vitro diagnostics in Europe
MTRC is an ISO 9001:2015 certified provider of Pan-European reimbursement services and products for Med Tech and IVD industry
MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry
Scope
Coding, payment mechanism, reimbursement tariffs, the pathway to create or improve reimbursement situation
Project-based on-demand work or >48 off-the-shelf syndicated reports
Countries
19 EU + Canada
Availability
Mixed
Scope
Seminars on introduction into market access for medical devices and IVD tests, seminars on reimbursement systems in individual countries (>70 reports)
Syndicated analytical reports on the topics of HTA, innovation funding, reimbursement of health apps
Countries
19 EU
Availability
Off-the-shelf
Scope
Subscription service with email alerts about initiated or published health technology assessments and reimbursement decisions for medical devices and in-vitro diagnostic tests from reimbursement (EU) and HTA (global) organizations
Countries
36 countries globally
Availability
On-demand
Scope
Development of health economic models for medical devices and IVD tests in European countries. Development of de novo and adaptation of existing models to new countries. Publication of results in peer-reviewed journals
Countries
EU and the US
Availability
On-demand
Scope
Development of systematic literature reviews and meta-analyses. Publication of results in peer-reviewed journals. Development of early and comprehensive value dossiers to support market access activities
Countries
EU and global
Availability
On-demand
Why us?
Pharma approach is put aside
Work with a company truly specialized in medical devices and diagnostics. Benefit from our topical knowledge from hundreds of projects
Getting results instantly (reports) or within 4-8 weeks (services)
Make business decisions quickly
17 out of top-30 companies choose MTRC for reimbursement support
Work with a provider who understands the industry’s needs. We served more than 150 clients over the last six years
More than 700 accomplished projects since 2017
Work with a provider who has experience in your field. We are ISO 9001:2015 certified and pay a lot of attention to maintain a good quality of services, including >300 internal instructions, regular quality management meetings, strict onboarding and training procedures
Team of 20 full-time employees in 6 countries
Unlike companies with an affiliate model, we do most services with in-house analysts ensuring greater quality, lower cost and predictable outcomes
MTRC is a thought leader in the field of European Med Tech reimbursement
MTRC has unique insights into market access through its various activities, including annual syndicated reports on the topics of HTA, innovation funding, reimbursement of digital health, comprehensive newsletter services, unparalleled educational platform and others
To stay up-to-date, we daily monitor developments of reimbursement systems in Europe
Subscribe to our newsletter to get updates every 2nd week
Only less than 10% of the news is reported in the free-of-charge newsletter. Access our paid services "HTA Alerts" and "Reimbursement Alerts" to get full, personalized reports from more than 90 reimbursement and HTA organizations in EU and globally. Request a three-month, free, no-obligation trial to understand the value to your organization
04 Oct 2022
A value dossier is a document of a certain structure that summarizes in a comprehensive and unbiased way all value-related messages for medical technology. The unique approach of MTRC is based on a deep understanding of evidence and data presentation requirements for market access processes in a large number of European countries.
24
Mar 2023
On March 2, 2023, the decision of the National Union of Health Insurance Funds relating to the update of the CCAM Nomenclature of procedure codes was published in the Official Journal of the French Republic. Changes include registration of new procedure codes, modification and removal of some existing codes. Newly introduced codes concern cardiovascular procedures, interventional radiology, orthopedics, peripheral vascular procedures, and others.
23
Mar 2023
In February 2023, the Scottish Health Technology Group, SHTG, released three MedTech-related assessments: selective internal radiation therapies (SIRT) for treating primary hepatocellular carcinoma, Feeling Good app, store-and-forward teledermatology for triage of primary care referrals.
22
Mar 2023
A new preeclampsia screening algorithm has been evaluated within the "New Method" framework since 2021. The algorithm helps to predict the risk of preeclampsia in the first trimester based on several parameters, including ultrasound examination and measurement of the Placenta Growth Factor (PIGF). In March 2023, the Decision Forum for "New Method" was held and commissioned to perform the implementation study of a new screening algorithm at St. Olav's Hospital.
21
Mar 2023
On March 8, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic on the coverage of the INTERVAPOR system for lung volume reduction under Forfait innovation program.
Our two core services are the provision of off-the-shelf and on-demand reimbursement analysis and the development of reimbursement strategy for medical devices in 19 European countries + Australia and Canada
| Analysis | |
Reimbursement
|
National fundingWillingness to pay for technology, based on:
|
| Strategy |
Reimbursement strategyPathway to get reimbursement:
|
Our services cover 19 European countries, including Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, Switzerland and Turkey + Australia and Canada
We provide services for major types of medical technologies
|
Implantable devices |
Interventional procedures |
Non-interventional procedures |
In-vitro diagnostic tests |
Medical aids |
|
Our analytical team has worked on hundreds of reimbursement projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring, use of fusidial markers, radiotherapy, endoscopy and more
|
Confidence in results
MTRC is ISO 9001:2015 certified organization (with the United Kingdom Accreditation Service, UKAS). We have established numerous procedures and services to ensure the high relevance and precision of our analysis in order to successfully guide your business decisions:
- Standard Operating Procedures and Work Instructions
- Access to official coding and DRG manuals, tariff lists and grouping software
- A team comprised of experienced Clinical Coders with a medical background
- Quick access to health authorities to address uncertainties
- Ongoing research program to get insights from payer and provider interviews
- All reports are reviewed by the CEO before release
Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries
Released reports:
|
Ongoing reports:
|